HCM
GSK icon

Herndon Capital Management’s GSK GSK Stock Holding History

Herndon Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$2K Buy
+30
New +$1.6K ﹤0.01% 194
2013
Q4 		– Sell
-3,986
Closed -$250K – 181
2013
Q3 		$250K Sell
3,986
-438
-10% -$28.2K ﹤0.01% 170
2013
Q2 		$276K Buy
+4,424
New +$281K ﹤0.01% 159

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Herndon Capital Management's GSK Position: Q2 2017 in Review

Herndon Capital Management opened a new position in GSK (GSK) in Q2 2017: 30 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #194 among its holdings. This is a return to the name: Herndon Capital Management previously reported a position in GSK as recently as Q3 2013.

Herndon Capital Management first reported a position in GSK in Q2 2013 and has held it in 3 quarters since. The position peaked at $276K in Q2 2013. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Herndon Capital Management held 30 shares of GSK worth $2K as of Q2 2017.
  • GSK was a new Herndon Capital Management position in Q2 2017.
  • GSK made up ﹤0.01% of Herndon Capital Management's portfolio in Q2 2017, its #194 holding.
  • Herndon Capital Management first reported a position in GSK in Q2 2013 and has held it in 3 quarters since.
  • Herndon Capital Management's GSK position peaked at $276K in Q2 2013.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Herndon Capital Management's 13F filing for Q2 2017, filed 4 Aug 2017.